Program

The program features nationally recognized exceptional early career research scholars who have demonstrated scientific achievements in cancer biology and neuroscience.

Time, events and speakers for the Rising Stars Symposium are subject to change. If there are updates, they will be published on this page. Times listed below are Eastern time.

All activities take place in Kinne Auditorium, Cannady Building 1.

To attend the symposium virtually, use the links below.

Wednesday, Feb. 28, 2024

5 p.m. Welcome
5:15 p.m. Plenary Talk Alfredo Quinones-Hinojosa, M.D.
Mayo Clinic
6 p.m. Reception — Hors d'oeuvres and Social Hour

Thursday, Feb. 29, 2024

8:40 a.m. Mechanisms of Neuroprotection of Deep Brain Stimulation of the Subthalamicnucleus: Redefining the Mission for DBS in Parkinson's Disease Suelen Lucio Boschen De Souza, Ph.D.
Mayo Clinic
9:20 a.m. Towards Understanding How Mutations in the p97 ATPase Cause ALS Malavika Raman, Ph.D.
Tufts University School of Medicine
10 a.m. Break
10:15 a.m. Metabolic Basis of Regulatory T-Cell Function: Role in Intestinal Homeostasis Wale O. Bamidele, Ph.D.
Mayo Clinic
10:55 a.m. Paxbp1 is Required for the Sustained Suppression of the Cytotoxic Program in T Cells Danielle Chisolm, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
11:35 a.m. Deconstructing Aging With Senolytic CAR-T Cells Corina Amor Vegas, M.D., Ph.D.
Cold Spring Harbor Laboratory
12:15 p.m. Lunch
1 p.m. "RNA switches” in pancreatic cancer: Expression, splicing and RNA-based therapeutics Luisa Escobar-Hoyos, M.Sc., Ph.D.
Yale School of Medicine
1:40 p.m. Cytoskeletal and Metabolic Drivers of Pancreatic Cancer Metastasis Gina Razidlo, Ph.D.
Mayo Clinic
2:20 p.m. Developing a Phase I/IIa Clinical Trial to Test Safety of an Autologous Retinal Pigment Epithelium Patch in Macular Degeneration Patients Kapil Bharti, Ph.D.
National Eye Institute